Internal Medicine, Hematology & Oncology · Memphis, TN
NPI
1528276763
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
80 Humphreys Center Dr Ste 330
Memphis, TN, 38120
Phone (901) 752-6131
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
1,148 services
Medicare patients, 2024
499
Average age 74
Drug cost, 2024
$3.4M
1,324 prescriptions
Company payments, 2025
$1,922
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amna G Khattak was code 99214 (office e&m - established), 493 times for 240 patients. In total Amna G Khattak billed 1,148 services in 22 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 493 | 240 | $64.09 | $32K |
| 99213 Office E&M - Established | Facility | 198 | 157 | $40.27 | $7,974 |
| 99233 Hospital E&M - Subsequent | Facility | 112 | 65 | $82.95 | $9,291 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 59 | 56 | $6.60 | $390 |
| 99214 Office E&M - Established | Office | 58 | 39 | $69.85 | $4,051 |
| 99213 Office E&M - Established | Office | 50 | 48 | $47.31 | $2,365 |
| 99203 Office E&M - New | Facility | 30 | 30 | $57.55 | $1,726 |
| 99204 Office E&M - New | Facility | 27 | 27 | $90.05 | $2,431 |
| 99443 Telephone Services | Facility | 25 | 23 | $65.77 | $1,644 |
| 99223 Hospital E&M - Initial | Facility | 19 | 19 | $121.95 | $2,317 |
| 99232 Hospital E&M - Subsequent | Facility | 16 | 11 | $54.21 | $867 |
By year: 2022 $8,075 for 109 services; 2023 $68K for 962 services; 2024 $68K for 1,148 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amna G Khattak prescribed most often to Medicare patients was Anastrozole, with 110 prescriptions and refills. In total Amna G Khattak wrote 1,324 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 110 | 166 | 27 | $1,310 |
| Eliquis Apixaban | 88 | 120 | 18 | $68K |
| Letrozole Generic | 66 | 148 | 23 | $1,191 |
| Warfarin Sodium Generic | 57 | 86 | 13 | $363 |
| Potassium Chloride Generic | 41 | 64 | 22 | $553 |
| Revlimid Lenalidomide | 40 | 40 | Under 11 | $634K |
| Dexamethasone Generic | 38 | 39 | 21 | $485 |
| Xarelto Rivaroxaban | 36 | 56 | Under 11 | $30K |
| Gabapentin Generic | 34 | 43 | 12 | $341 |
| Ondansetron Hcl Generic | 33 | 33 | 21 | $952 |
| Acyclovir Generic | 31 | 37 | Under 11 | $338 |
| Jakafi Ruxolitinib Phosphate | 31 | 31 | Under 11 | $505K |
| Hydroxyurea Generic | 28 | 66 | Under 11 | $548 |
| Ondansetron Odt Ondansetron | 26 | 26 | 23 | $417 |
| Furosemide Generic | 25 | 33 | Under 11 | $35.3 |
Brand drugs: 363 claims; generic drugs: 961 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amna G Khattak $1,922 ($1,922 in general payments such as food, travel and fees) from 26 companies. The largest payer was Daiichi Sankyo Inc. with $213.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 8 | $213 |
| Celgene Corporation BMY | 7 | $184 |
| Pfizer Inc. PFE | 8 | $160 |
| Abbvie Inc. ABBV | 7 | $158 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $151 |
| Array Biopharma Inc PFE | 5 | $98.47 |
| Janssen Biotech, Inc. JNJ | 4 | $95.32 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $87.81 |
| Pharmacosmos Therapeutics Inc. | 4 | $85.3 |
| GlaxoSmithKline, LLC. GSK | 4 | $84.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.